Opyl Limited

Opyl is a new generation company that provides leading biopharma and health organisations access to emerging AI-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery.

Utilising Opyl novel digital platforms, artificial intelligence tools, data analysis methodologies, and Opyl’s health subject matter and market expertise, we provide our clients with actionable solutions and competitive insight into the real lived experience of patients and healthcare providers managing an illness, injury or disorder.

The actionable insights Opyl deliver give our clients clear competitive advantage that can be transformative in helping them to achieve the validation, improvement, advancement and adoption of their innovative technologies and clinical interventions.

Opyl know that patients report more about their health experience to social networks and digital platforms than they do to their doctor.

Opyl point of difference is the deep healthcare marketing and data science expertise of our diverse team and our understanding of real world data, particularly patient reported outcomes (PRO) and the continuous data and dialogue stream within social media.

Opyl is investing in researching and developing new technologies as well as providing competitive digital marketing and insights services to healthcare, wellness and science technology-focussed clients.

Although Opyl headquarters are based in Melbourne, Opyl have client service and development teams in both Australia and the US.